Bright Cell, Inc.
Clinical trials sponsored by Bright Cell, Inc., explained in plain language.
-
First human test of experimental treatment for early menopause
Disease control Not yet recruitingThis early-stage study will test the safety of an experimental treatment called YB-1113 for women with premature ovarian insufficiency (early menopause). Six women aged 18-40 will receive the treatment through an IV infusion. Researchers will monitor for side effects and measure …
Phase: PHASE1 • Sponsor: Bright Cell, Inc. • Aim: Disease control
Last updated Feb 27, 2026 15:19 UTC
-
New injection tested to smooth smile lines
Symptom relief Not yet recruitingThis is an early study to check the safety of a new injectable treatment called BC-101 for moderate to severe smile line wrinkles. A small group of healthy adults who are unhappy with their wrinkles will receive the injections. Researchers will watch for side effects and see if t…
Phase: PHASE1 • Sponsor: Bright Cell, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC